Cathie Wood-led ARK Investment Management’s flagship fund ARK Innovation ETF’s (NYSE: ARKK) performance during the third quarter was mixed relative to broad-based indexes, as it outperformed the MSCI World Index but under
Gainers
Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
On CNBC’s "Mad Money Lightning Round," Jim Cramer said UiPath Inc (NASDAQ: PATH) is losing money, and he is not recommending companies that are losing money.
Cathie Wood-led ARK Investment Management dumped over 200,000 shares of Spotify Technology SA (NYSE: SPOT) on Friday via two of the company’s exchange-traded funds (ETFs).